![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
Sir Greg Winter (Master, Trinity College, University of Cambridge)
Friday 03 August 2012, 17:00-18:00
The rise of antibody pharmaceuticals and their future
- đ¤ Speaker: Sir Greg Winter (Master, Trinity College, University of Cambridge)
- đ Date & Time: Friday 03 August 2012, 17:00 - 18:00
- đ Venue: Lecture Theatre, Department of Physiology, Development and Neuroscience (PDN)
Questions? Contact
Phil Brereton
Abstract
Sir Greg Winter, Ph.D., FRS , (Master, Trinity College, University of Cambridge) is a British biochemist and a pioneer of therapeutic monoclonal antibodies who invented techniques to humanise antibodies using phage display for therapeutic uses. He founded Cambridge Antibody Technology (acquired by Astrazeneca in 2006 for ÂŖ702m) and Bicycle Therapeutics and is on the Scientific Advisory Board of Covagen.
Series This talk is part of the Cambridge Science Summer School 2012 series.
Included in Lists
- Cambridge Infectious Diseases
- Lecture Theatre, Department of Physiology, Development and Neuroscience (PDN)
Note: Ex-directory lists are not shown.